Deletion of Chromosomes 13q and 14q Is a Common Feature of Tumors with BRCA2 Mutations
暂无分享,去创建一个
Gaëtan MacGrogan | Aurélien de Reyniès | E. Letouzé | G. MacGrogan | R. Iggo | N. Sevenet | N. Elarouci | A. de Reyniès | I. Coupier | E. Barouk-Simonet | M. Longy | Richard Iggo | F. Bonnet | Isabelle Coupier | Nabila Elarouci | Eric Letouzé | Michel Longy | Audrey Rouault | Guillaume Banneau | Natalie Jones | Emmanuelle Barouk-Simonet | Laurence Venat | Françoise Bonnet | Nicolas Sévenet | G. Banneau | L. Venat | A. Rouault | N. Jones
[1] Gordon K Smyth,et al. Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .
[2] S. Boulton. Cellular functions of the BRCA tumour-suppressor proteins. , 2006, Biochemical Society transactions.
[3] P. Møller,et al. Genetic epidemiology of BRCA mutations--family history detects less than 50% of the mutation carriers. , 2007, European journal of cancer.
[4] D. Botstein,et al. Cluster analysis and display of genome-wide expression patterns. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[5] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[6] Stephen Fox,et al. Subtypes of familial breast tumours revealed by expression and copy number profiling , 2010, Breast Cancer Research and Treatment.
[7] Rafael A Irizarry,et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. , 2003, Biostatistics.
[8] Petra M. Nederlof,et al. Analysis of PALB2/FANCN-associated breast cancer families , 2007, Proceedings of the National Academy of Sciences.
[9] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[10] N. Pavletich,et al. The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA–ssDNA junction , 2005, Nature.
[11] Jean YH Yang,et al. Bioconductor: open software development for computational biology and bioinformatics , 2004, Genome Biology.
[12] O. Johannsson,et al. Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes , 2009, Breast Cancer Research.
[13] P. Devilee,et al. Prediction of BRCA2-association in hereditary breast carcinomas using array-CGH , 2012, Breast Cancer Research and Treatment.
[14] E. Lander,et al. Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma , 2007, Proceedings of the National Academy of Sciences.
[15] J Isola,et al. Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. , 1997, Cancer research.
[16] M. Daly,et al. PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.
[17] M. Ringnér,et al. Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics , 2010, Breast Cancer Research.
[18] Tara L. Naylor,et al. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. , 2005, Cancer research.
[19] Thomas Helleday,et al. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase , 2005, Nature.
[20] Olufunmilayo I. Olopade,et al. Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations , 2007, Nature Reviews Cancer.
[21] Tom Walsh,et al. Ten genes for inherited breast cancer. , 2007, Cancer cell.
[22] R. Greenberg,et al. Multifactorial contributions to an acute DNA damage response by BRCA1/BARD1-containing complexes. , 2006, Genes & development.
[23] I. de Mascarel,et al. Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations , 2010, Breast Cancer Research.
[24] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[25] E. Dougherty,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[26] D. Easton,et al. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13. , 1995, Oncogene.
[27] Alan Ashworth,et al. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy , 2005, Nature.